| 1 |
Development of the asthma control test
Robert A. Nathan, Christine A. Sorkness, Mark R. Kosinski et al. · Journal of Allergy and Clinical Immunology
|
2004 |
2,939 |
| 2 |
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists
Michael N. Schatz, Christine A. Sorkness, James T. Li et al. · Journal of Allergy and Clinical Immunology
|
Mar 2006 |
1,235 |
| 3 |
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Nicola Alexander Hanania, Michael James Noonan, Jonathan Corren et al. · Thorax
Open access |
22 May 2015 |
382 |
| 4 |
Absence of Growth Retardation in Children With Perennial Allergic Rhinitis After One Year of Treatment With Mometasone Furoate Aqueous Nasal Spray
Eric J. Schenkel, David P. Skoner, Edwin A. Bronsky et al. · PEDIATRICS
|
Feb 2000 |
357 |
| 5 |
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks
Aleena Banerji et al. · JAMA
Open access |
27 Nov 2018 |
310 |
| 6 |
Antimicrobial Peptides Human β-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells
François Niyonsaba, Hiroko Ushio, Mutsuko Hara et al. · The Journal of Immunology
|
26 Feb 2010 |
282 |
| 7 |
Predicting Response to Omalizumab, an Anti-IgE Antibody, in Patients With Allergic Asthma
Jean Bousquet, Sally E. Wenzel, Stephen T. Holgate et al. · CHEST Journal
|
Apr 2004 |
278 |
| 8 |
Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities
Nicole Frahm et al. · Journal of Virology
Open access |
12 Feb 2004 |
276 |
| 9 |
Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder—A Randomized, Controlled 12-Month Trial
James B. Adams, TAPAN K. AUDHYA, Elizabeth Geis et al. · Nutrients
Open access |
17 Mar 2018 |
273 |
| 10 |
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
C.-G. Löfdahl, T.F. Reiss, Jared A. Leff et al. · BMJ
Open access |
10 Jul 1999 |
267 |
| 11 |
Broad Specificity of Virus-Specific CD4+T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection
Cheryl L. Day, Georg Michael Lauer, Gregory K. Robbins et al. · Journal of Virology
Open access |
18 Nov 2002 |
257 |
| 12 |
NC/Nga Mice: A Mouse Model for Atopic Dermatitis
Hajime Suto, Hiroshi Matsuda, Koichi Mitsuishi et al. · International Archives of Allergy and Immunology
|
1999 |
250 |
| 13 |
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
Hilary J Longhurst et al. · New England Journal of Medicine
Open access |
22 Mar 2017 |
238 |
| 14 |
Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
Fabio Candotti et al. · Blood
Open access |
13 Sep 2012 |
236 |
| 15 |
Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial
William R. Lumry, H. Henry Li, Robyn J. Levy et al. · Annals of Allergy Asthma & Immunology
|
10 Oct 2011 |
229 |
| 16 |
Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes
Julian Schulze zur Wiesch, Georg Michael Lauer, Cheryl L. Day et al. · The Journal of Immunology
|
Sep 2005 |
191 |
| 17 |
Assessing Future Need for Acute Care in Adult Asthmatics
Molly L. Osborne, Kathryn L. Pedula, Mark T. O’Hollaren et al. · CHEST Journal
|
16 Jun 2007 |
186 |
| 18 |
Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities
Georg Michael Lauer, Kei Ouchi, Raymond T. Chung et al. · Journal of Virology
Open access |
15 Jun 2002 |
185 |
| 19 |
Omalizumab is effective in the long-term control of severe allergic asthma
Bobby Quentin Lanier, Jonathan Corren, William R. Lumry et al. · Annals of Allergy Asthma & Immunology
|
Aug 2003 |
185 |
| 20 |
Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance ofgagandnefand the Presence of Broadly Recognized Peptides
Daniel E. Kaufmann, Paul M Bailey, John Sidney et al. · Journal of Virology
Open access |
12 Apr 2004 |
179 |
| 21 |
Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human α-defensins from neutrophils
Yan Zheng, François Niyonsaba, Hiroko Ushio et al. · British Journal of Dermatology
|
4 Oct 2007 |
178 |
| 22 |
Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group
M.J. Noonan, Paul Chervinsky, M. Brandon et al. · European Respiratory Journal
Open access |
Jun 1998 |
176 |
| 23 |
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
Michael James Noonan, Phillip E. Korenblat, Sofia Mosesova et al. · Journal of Allergy and Clinical Immunology
|
29 May 2013 |
172 |
| 24 |
Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial
Stephen T. Holgate, Michael James Noonan, Pascal Chanez et al. · European Respiratory Journal
Open access |
25 Nov 2010 |
167 |
| 25 |
The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma
Roland Buhl, Gerald Hanf, Mauricio Ruiz Soler et al. · European Respiratory Journal
Open access |
Nov 2002 |
160 |
| 26 |
Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial
Jennifer M. Maloney, David I. Bernstein, Harold S. Nelson et al. · Annals of Allergy Asthma & Immunology
|
21 Dec 2013 |
158 |
| 27 |
Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device
Frank C. Hampel, Paul H. Ratner, Julius van Bavel et al. · Annals of Allergy Asthma & Immunology
|
Aug 2010 |
155 |
| 28 |
Cross-Reactivity of Plant and Animal Allergens
Richard W. Weber · Clinical Reviews in Allergy & Immunology
|
2001 |
154 |
| 29 |
Childhood Obesity and Asthma Control in the GALA II and SAGE II Studies
Luisa N. Borrell, Elizabeth A. Nguyen, Lindsey A. Roth et al. · American Journal of Respiratory and Critical Care Medicine
Open access |
8 Feb 2013 |
144 |
| 30 |
Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis
Paul H. Ratner, Frank C. Hampel, Julius van Bavel et al. · Annals of Allergy Asthma & Immunology
|
2008 |
135 |
| 31 |
Cytotoxicity Assessment of Some Carbon Nanotubes and Related Carbon Nanoparticle Aggregates and the Implications for Anthropogenic Carbon Nanotube Aggregates in the Environment
Lawrence E. Murr, Kristine M. Garza, K. F. Soto et al. · International Journal of Environmental Research and Public Health
Open access |
30 Apr 2005 |
133 |
| 32 |
Drug‐Induced Sleep Endoscopy and Surgical Outcomes: A Multicenter Cohort Study
Katherine K. Green, David T. Kent, Mark A. D׳Agostino et al. · The Laryngoscope
Open access |
27 Dec 2018 |
131 |
| 33 |
The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients
Sandra M. Gawchik, Consuelo L. Saccar, Michael James Noonan et al. · Journal of Allergy and Clinical Immunology
Open access |
Apr 1999 |
128 |
| 34 |
Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma
Stanley James Szefler, James Baker, Tom Uryniak et al. · Journal of Allergy and Clinical Immunology
|
Nov 2007 |
120 |
| 35 |
Nasal Airway Obstruction: Prevalence and Anatomic Contributors
David W. Clark, Anthony G. Del Signore, Roheen Raithatha et al. · Ear Nose & Throat Journal
Open access |
Jun 2018 |
116 |
| 36 |
Effects of montelukast and beclomethasone on airway function and asthma control
Elliot Israel, Paul Chervinsky, Bruce F. Friedman et al. · Journal of Allergy and Clinical Immunology
Open access |
Dec 2002 |
114 |
| 37 |
Remibrutinib in Chronic Spontaneous Urticaria
Martin Metz, A.M. Giménez-Arnau, Michihiro Hide et al. · New England Journal of Medicine
|
5 Mar 2025 |
111 |
| 38 |
Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
Aleena Banerji, Jonathan A. Bernstein, Douglas T Johnston et al. · Allergy
Open access |
21 Jul 2021 |
108 |
| 39 |
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
Marcus A. Altfeld, Marylyn M. Addo, Robert L. Eldridge et al. · The Journal of Immunology
|
Sep 2001 |
107 |
| 40 |
Current state of hereditary angioedema management: A patient survey
Aleena Banerji, Paula Jane Busse, Sandra C. Christiansen et al. · Allergy and Asthma Proceedings
Open access |
May 2015 |
104 |
| 41 |
The Human Cathelicidin LL-37 Host Defense Peptide Upregulates Tight Junction-Related Proteins and Increases Human Epidermal Keratinocyte Barrier Function
Toshihiro Akiyama, François Niyonsaba, Chanisa Kiatsurayanon et al. · Journal of Innate Immunity
Open access |
2014 |
104 |
| 42 |
Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses
Georg Michael Lauer, Tam Nguyen, Cheryl L. Day et al. · Journal of Virology
Open access |
15 Mar 2002 |
104 |
| 43 |
Portable flanking sequences modulate CTL epitope processing
Sylvie Le Gall, Pamela Stamegna, Bruce D. Walker · Journal of Clinical Investigation
Open access |
Nov 2007 |
102 |
| 44 |
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
William R. Lumry, Timothy Craig, Bruce L. Zuraw et al. · The Journal of Allergy and Clinical Immunology In Practice
Open access |
31 Jan 2018 |
101 |
| 45 |
Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients
José María Ayuso, Marı́a Virumbrales-Muñoz, Patrick H. McMinn et al. · Lab on a Chip
Open access |
2019 |
98 |
| 46 |
Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies
Mark R. Stein, Robert P. Nelson, Joseph A. Church et al. · Journal of Clinical Immunology
Open access |
23 Sep 2008 |
96 |
| 47 |
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
Brian P. Vickery et al. · The Journal of Allergy and Clinical Immunology In Practice
Open access |
24 Dec 2020 |
93 |
| 48 |
Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler
Michael James Noonan, Jill P. Karpel, George W. Bensch et al. · Annals of Allergy Asthma & Immunology
|
2001 |
93 |
| 49 |
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler
David I. Bernstein et al. · Respiratory Medicine
Open access |
Sep 1999 |
92 |
| 50 |
Immunological and Virological Impact of Highly Active Antiretroviral Therapy Initiated during Acute HIV‐1 Infection
Hendrik Streeck, Heiko K. Jessen, Galit Alter et al. · The Journal of Infectious Diseases
Open access |
22 Aug 2006 |
90 |